ArticleHaematologica2018
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma.
Ziduo Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papertrialcites it
ArticleHaematologica2018
Ziduo Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.